ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RENX Renalytix Plc

27.50
-0.50 (-1.79%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Renalytix Plc LSE:RENX London Ordinary Share GB00BYWL4Y04 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -1.79% 27.50 27.00 28.00 29.00 27.50 28.00 326,997 15:09:30
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Services, Nec 3.4M -46.22M -0.4626 -0.59 27.48M
Renalytix Plc is listed in the Services sector of the London Stock Exchange with ticker RENX. The last closing price for Renalytix was 28p. Over the last year, Renalytix shares have traded in a share price range of 10.25p to 145.00p.

Renalytix currently has 99,930,156 shares in issue. The market capitalisation of Renalytix is £27.48 million. Renalytix has a price to earnings ratio (PE ratio) of -0.59.

Renalytix Share Discussion Threads

Showing 501 to 523 of 2800 messages
Chat Pages: Latest  28  27  26  25  24  23  22  21  20  19  18  17  Older
DateSubjectAuthorDiscuss
31/7/2020
05:41
The Kantaro website has been updated in several areas, and as suspected the antibody test availability has been delayed, with the 'patient version' expected to be available at the end of August. However, there does appear to have been important progress as they state that the COVID-SeroIndex™, which is FDA cleared (presumably based on the Mount Sinai version granted EUA in April), is for vaccine developers and will hopefully be available at scale during August 2020 -



I note that because Kantaro’s antibody test allows you to monitor the amount of antibodies you have, patients are encouraged to test more than once -

Antibody Test Kits
We thank you for your interest in Kantaro’s SARS-CoV-2 IgG Antibody Test Kit. The test is expected to be available by the end of August. Please discuss with your physician about ordering a test from your local testing facility.

Kantaro’s groundbreaking COVID-19 antibody tests will tell you the number of antibodies you have, making for more accurate, reliable and measurable results so you can manage your health and well-being.

Accurate
Unlike most other tests, which just tell you whether you are positive/negative for COVID-19 antibodies, Kantaro’s test tells you the number of potentially neutralizing (anti-virus) antibodies in your system, which can give you a more precise. understanding of your health and well-being, including your likelihood of re-infection.

Knowing the amount of anti-virus antibodies you have — your antibody number — is the first step towards an informed future for you, your family and your community.

Proven
Mount Sinai developed the technology underlying Kantaro’s kits during the height of the COVID-19 outbreak in New York City, designing the test to set the standard in antibody testing.

As of June 2020, Mount Sinai has successfully used the antibody testing technology now found in the Kantaro kit over 50,000 times across a highly diverse population.

Accessible
We believe everyone deserves access to important information about their health, so the Kantaro antibody test is designed to be easily used in laboratories all over the world.

Because Kantaro’s antibody test allows you to monitor the amount of antibodies you have, we encourage you to get our test more than once.

With your Kantaro test results, you can do your part to help the world recover from COVID-19 by donating plasma or joining our patient informational dashboard, which will speed the search for a treatment or a vaccine.

Prior to the Kantaro test being able to be ordered it is available at the Mount Sinai Health System who ask for individuals volunteering to donate convalescent plasma, as well as healthcare workers and first responders. To learn more, please visit Mount Sinai’s Convalescent Plasma Program website. If you are interested in donating plasma, please complete Mount Sinai’s COVID-19 Plasma Donation Form.



I assume that we may get some form of update accordingly.

wan
30/7/2020
16:44
Quite interesting - large trades allowing in new buyers and sellers out. The banks will imo be flipping their over allotment shares... they just view them as part of their fee most of the time.
nimbo1
29/7/2020
00:21
We might hear news on the COVID kit production first
melody9999
28/7/2020
19:29
All looking very solid, I’m in the same boat of being excited about the next RNS to see how it’s received in the US - fingers crossed it’s the Mount Sinai launch of KidneyIntelX
74tom
28/7/2020
19:15
15.78 now. Looking strong today.
mr roper
28/7/2020
18:21
Yup. The consolidation has cooled off the rsi nicely. Next leg up could be a substantial one.

Rnlx positive on the day now.

mr roper
28/7/2020
17:17
Loving the period of consolidation and decent volume.

Excited for first news post adr listing

nimbo1
27/7/2020
23:11
15.49 close.onwards and upwards
mr roper
27/7/2020
21:22
On Marketsmith it says $RNLX Has earnings due in 1 day
shoee62
27/7/2020
20:48
Don’t think we are at new highs yet, highest intraday was 15.89 a few days back. Looks like we’ll blast it out the way this week though. I reckon news is coming.
mr roper
27/7/2020
18:56
Yup - new highs on the NASDAQ...
someuwin
27/7/2020
17:26
intra day ATH's on nasdaq now. 15.7 - even if it doesn't hold nice to see demand : )
nimbo1
27/7/2020
13:47
Very under appreciated aspect of Physiomics business model is how it can adapt its Virtual Tumour model (used to advise Biotech/Pharma clients on cancer drug R&D) into potential front line use in Personalised Oncology treatment as a Decision Support Tool for clinicians

This sort of access to NHS Data ( 400 Oesophageal Cancer patients)
+ Collaborations with
Oxford University and NHS academics/clinicians is really not understood by your average investor

There are a lot of well funded start ups in Personalised Oncology/Medicine AI/ML which are already Unicorns (Tempus, GRAIL, FlatIron, Benevolent AI etc) who would kill for this Company's model/expertise/relationships/Customers etc

the stigologist
27/7/2020
11:51
Yes positive to see the broker option taken in full - no surprise given the price has been trading around $15 so far...
74tom
27/7/2020
11:09
tobby3 spam - filter him
melody9999
27/7/2020
10:18
Good to see the over allotment take up. Another 10m bucks in to the coffers.
mr roper
25/7/2020
13:41
some valuation comparators
the stigologist
23/7/2020
21:44
15.41 buck finish
mr roper
23/7/2020
21:07
Good day in view of the market's fall.
busterdog2
23/7/2020
20:04
Would be expecting some news next week. Would be nice to finish this week consolidating above 15 bucks
mr roper
23/7/2020
18:53
Yes US price now 15.5 or 6.08 equivalent. Must have been my buying this morning (I wish! ; ))
nimbo1
23/7/2020
18:45
It’s looking very promising so far, should be some serious volume once newsflow resumes. And a very good day on AIM with afternoon buyers (Americans?) driving up the price, albeit still at a discount to the US.
74tom
23/7/2020
18:24
Nicely up in the US again.

NASDAQ:RNLX

someuwin
Chat Pages: Latest  28  27  26  25  24  23  22  21  20  19  18  17  Older

Your Recent History

Delayed Upgrade Clock